{
  "id": "health-financing",
  "title": "Health Financing",
  "lang": "en",
  "source_lang": "en",
  "summary": "Health financing comprises the collection, pooling, and allocation of funds to support health services and protect people from financial hardship.",
  "category": "health",
  "subcategory": "public-health",
  "type": "concept",
  "aliases": [
    "Healthcare financing",
    "health care financing"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/health-financing/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/health-financing/",
      "json": "https://aiwiki.page/zh/health-financing.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Health financing is the set of arrangements through which money is raised, pooled, and used to pay for health services and related activities. It is a central function of a health system, alongside service delivery, workforce development, and governance. Financing arrangements determine not only how much money is available, but also who contributes, who receives services, which services are covered, and how providers are paid. They encompass government budgets, compulsory and voluntary insurance, household payments, and external assistance.\n\nThe principal objectives of health financing include enabling access to needed services, protecting households against financial hardship, distributing resources fairly, and using available funds efficiently. These objectives are central to universal health coverage, which concerns access to needed quality services without financial hardship. Raising expenditure alone does not establish universal coverage: the organization of financing affects whether resources reach underserved populations, whether payments discourage treatment, and whether providers have incentives to deliver appropriate care.\n\nHealth financing combines questions of economics, public finance, institutional design, and health policy. Its analysis distinguishes the sources of money from the institutions that manage it and the mechanisms that distribute it. Most countries combine several arrangements rather than operating a single, internally uniform financing model."
    },
    {
      "heading": "Core functions and economic foundations",
      "text": "Health financing is commonly analyzed through three interrelated functions: revenue raising, pooling, and purchasing. Revenue raising concerns how money enters the system, including taxes, compulsory contributions, insurance premiums, direct payments, and transfers from abroad. Pooling concerns the accumulation and management of prepaid funds on behalf of a population. Purchasing concerns how those funds are allocated to providers for services, medicines, infrastructure, or other activities. One organization may perform several functions, or responsibility may be divided among ministries, insurance funds, local governments, and specialized agencies.\n\nThese functions matter because healthcare needs and costs are unevenly distributed and often unpredictable. A person may require little care for several years and then need prolonged treatment or emergency surgery. Payment at the moment of illness concentrates expenditure precisely when illness may also reduce earnings. Prepayment separates contributions from the immediate use of services, while pooling spreads financial risk across people and time. Insurance cannot eliminate the underlying cost of illness, but it can alter who bears that cost and when.\n\nHealthcare markets also exhibit information problems. Patients generally know less than clinicians about which services are necessary, while insurers may know less than applicants about their expected healthcare needs. Kenneth Arrow’s 1963 article, “Uncertainty and the Welfare Economics of Medical Care,” helped establish uncertainty and information asymmetry as central themes in health economics. These characteristics help explain the importance of professional regulation, public financing, insurance rules, and institutions that assess treatment effectiveness.\n\nTwo concepts require particular care. Adverse selection occurs when people with higher expected costs are more likely to seek insurance, potentially increasing premiums and discouraging lower-risk enrollment. Moral hazard, in insurance economics, refers to changes in behavior when insurance alters the price or consequences of an action. Reduced prices at the point of use may increase service use, but the additional care may be beneficial, unnecessary, or harmful; the term does not imply misconduct.\n\nFinancing also addresses services whose benefits extend beyond the individual recipient. Public health surveillance, outbreak investigation, and some preventive interventions cannot be financed adequately through individual clinical bills alone. Vaccination can generate benefits for others through reduced transmission, although the size of this effect depends on the pathogen and vaccine. Public financing can support these collective benefits while also funding individual treatment. The balance between such functions depends on disease patterns, service capacity, and public priorities."
    },
    {
      "heading": "Historical development and institutional models",
      "text": "Modern health financing developed from overlapping traditions of charitable provision, mutual aid, employer benefits, local public services, and state social protection. Before comprehensive national arrangements emerged, hospitals and practitioners often relied on direct patient payments, religious or charitable funding, and municipal support. Occupational and community mutual-aid societies collected regular contributions to cover illness-related costs. These organizations demonstrated the possibilities of prepayment but frequently covered restricted populations and offered limited protection against expensive illness.\n\nGermany’s 1883 sickness insurance legislation, enacted under Chancellor Otto von Bismarck, established compulsory insurance for specified groups of workers. Contributions from workers and employers supported sickness funds that provided defined benefits. Coverage subsequently expanded, and social health insurance became influential in several European countries. Its historical association with formal employment remains important: payroll-based collection is relatively straightforward for registered wage earners but more difficult where self-employment and informal work are extensive.\n\nA different institutional tradition finances services predominantly through general government revenue. The United Kingdom established its National Health Service in 1948, following wartime planning and legislation in 1946. The service brought broad entitlement and predominantly tax-funded provision into a national framework. The frequently used label “Beveridge model” refers to this general tradition, although William Beveridge’s 1942 report addressed a wider system of social security rather than specifying every feature of the later health service.\n\nOther countries combined these traditions in distinctive ways. Canada’s publicly financed insurance developed through provincial initiatives, including Saskatchewan’s hospital insurance in 1947 and medical care insurance in 1962, followed by federal legislation supporting wider adoption. In the United States, Medicare and Medicaid were established in 1965 alongside an extensive employment-based insurance sector. Japan achieved universal health insurance coverage in 1961 through multiple employment-based and residence-based schemes. These examples illustrate that broad coverage can emerge through different sequences of institutional expansion.\n\nLabels such as tax-funded system, social health insurance, national health insurance, and private insurance are useful shorthand, but they can conceal important similarities. Payroll contributions may be supplemented heavily by taxes; tax-funded services may purchase care from private providers; and private insurance may operate under compulsory enrollment and extensive regulation. Public financing does not necessarily mean public ownership of facilities, just as private delivery does not necessarily mean direct household payment. Contemporary comparison therefore examines actual revenue flows, pooling arrangements, entitlements, and payment rules rather than treating historical models as complete descriptions."
    },
    {
      "heading": "Revenue raising and the distribution of contributions",
      "text": "Health revenue comes principally from government revenue, compulsory insurance contributions, voluntary prepayment, direct household spending, and external transfers. General government revenue includes taxes on income, consumption, property, and other activities, as well as nontax receipts. Compulsory insurance contributions are often assessed on wages or earnings. These categories can overlap in practice: a social insurance fund may receive substantial budget transfers to cover children, pensioners, unemployed people, or other groups whose contributions do not finance their expected costs.\n\nThe distributional effect of a revenue source depends on who ultimately bears its economic burden, not simply who submits the payment. An employer payroll contribution may affect wages, employment costs, or prices. A consumption tax may absorb a larger share of lower-income households’ resources, while exemptions, transfers, and the broader tax system can alter the overall distribution. Taxation therefore has to be assessed together with contribution rules and expenditure benefits rather than classified as equitable or inequitable solely by its name.\n\nCompulsory payroll financing has an administratively accessible base where formal employment is widespread. It becomes more difficult to extend when workers have irregular earnings, employers are unregistered, or income is hard to verify. Flat premiums can be especially burdensome for low-income households and may cause interrupted enrollment if payment is a condition of coverage. Budget-financed subsidies can address these gaps, but identifying eligible households and maintaining current records require administrative capacity.\n\nSome governments earmark particular revenues for health, including portions of tobacco, alcohol, or other excise taxes. Such taxes may serve both revenue and disease prevention objectives by increasing the prices of harmful products. Earmarking can make funding commitments more visible, but it does not guarantee a corresponding increase in total health expenditure: other budget allocations may be reduced. Revenue also depends on consumption, tax design, enforcement, and economic conditions. A declining taxable activity may be consistent with a public health objective even when it limits revenue growth.\n\nThe distinction between prepaid revenue and payment at the point of service is particularly consequential. Taxes and insurance contributions are generally collected before illness occurs. Direct payments are made when care or medicines are obtained and offer little opportunity for redistribution between healthy and sick people. Voluntary charitable donations and crowdfunding can meet particular expenses, but their availability is uneven and does not constitute a predictable entitlement. Sustainable revenue raising consequently concerns adequacy, stability, collection costs, and fairness as well as the nominal amount collected."
    },
    {
      "heading": "Risk pooling, fragmentation, and redistribution",
      "text": "Risk pooling combines prepaid resources so that the cost of care is not borne solely by the individual who becomes ill. It supports redistribution from people with lower current healthcare needs to those with higher needs. Depending on contribution rules and subsidies, it can also redistribute from higher-income to lower-income groups and across generations. These transfers are not incidental: they are central to the financial protection offered by collective financing.\n\nThe number of members matters, but pool size alone does not determine performance. A pool must also have adequate revenue and a sufficiently balanced distribution of risks. A large pool of people with very low contributions may remain unable to finance an adequate package, while a smaller high-income pool may have ample resources. Geographical concentration can expose a pool to correlated risks, such as a local epidemic or natural disaster. Transfers, reserves, and reinsurance can help manage these exposures, subject to the wider system’s financial capacity.\n\nFragmentation occurs when prepaid funds are divided among groups with limited redistribution between them. Separate arrangements for civil servants, formal-sector employees, low-income households, and particular regions may have different contribution levels, provider networks, and benefit packages. Such divisions can preserve unequal access even when nearly everyone belongs to some scheme. Fragmentation can also increase administrative costs and weaken purchasing power, although decentralized arrangements may allow local responsiveness or reflect constitutional divisions of authority.\n\nSystems address fragmentation through several mechanisms. Funds may be merged, common benefit rules introduced, or government transfers used to equalize resources. Risk adjustment distributes money according to expected healthcare need rather than enrollment numbers alone. A simplified allocation to fund \\(i\\) can be expressed as:\n\n\\[A_i = N_i \\times r_i \\times b,\\]\n\nwhere \\(N_i\\) is the number of covered people, \\(r_i\\) is a relative expected-cost weight, and \\(b\\) is a base allocation. Actual formulas may incorporate age, morbidity, socioeconomic conditions, or geographical costs. Formula design must also consider incentives to improve coding, select favorable risks, or avoid costly patients.\n\nA single national pool is not the only possible route to redistribution. Multiple insurers can operate with standardized entitlements, regulated enrollment, and strong equalization transfers. Conversely, nominally unified financing can remain fragmented through separate budget lines or privileged access to providers. The relevant question is how effectively resources follow population need. Portability also matters: people who move, change employment, or cross administrative boundaries may lose practical access even when their formal entitlement continues."
    },
    {
      "heading": "Entitlement, benefit packages, and access",
      "text": "Health coverage has several distinct dimensions: who is entitled, which services are included, and how much of the cost is covered. Formal enrollment addresses only the first dimension. A person may be insured yet face exclusions, high copayments, unavailable medicines, distant facilities, or providers that do not accept the scheme. Financing analysis therefore distinguishes legal entitlement from effective access and from actual receipt of appropriate, good-quality care.\n\nA health benefit package specifies the services, products, or conditions covered by a financing arrangement. It may be defined through a positive list of covered services, a negative list of exclusions, broad statutory rights, or combinations of these approaches. Operational rules are equally important: referral requirements, prior authorization, limits on treatment frequency, and restrictions to contracted providers can substantially shape access. An entitlement to a medicine is incomplete if its dosage, indication, prescribing conditions, or reimbursement price is unclear.\n\nPackage design requires choices because financial, workforce, and infrastructure resources are finite. Considerations include disease burden, clinical effectiveness, budget impact, equity, and protection against unusually expensive illness. Health technology assessment examines the clinical, economic, organizational, and sometimes ethical implications of technologies and services. Economic evaluation may use quality-adjusted life-years or disability-adjusted life-years, but these measures do not by themselves resolve every allocation question. Severity, unmet need, uncertainty, and the distribution of benefits may also matter.\n\nCost-effectiveness and affordability are different. A treatment can provide substantial benefit relative to its cost while still requiring a large total budget because many people are eligible. Conversely, a treatment for a rare condition may have a limited aggregate budget impact despite a high cost per patient. Decisions also depend on what services would be displaced. Funding a new intervention from a fixed budget has an opportunity cost if it reduces resources available for other effective care.\n\nCost sharing includes deductibles, copayments, and coinsurance. These mechanisms reduce the share paid by the financing scheme and may influence utilization, but patients may reduce necessary as well as unnecessary care. Exemptions for selected services or population groups, together with annual payment ceilings, can modify the effects. Implementation remains decisive: complicated exemption procedures may leave eligible people paying. Coverage design also has to account for transport, accommodation, and income lost during treatment, which can obstruct access even when clinical services themselves carry no charge."
    },
    {
      "heading": "Purchasing services and paying providers",
      "text": "Strategic purchasing uses information about population needs, provider performance, and available resources to decide what to purchase, from whom, and under what payment and contractual conditions. It differs from simply reimbursing historical expenditure or paying bills without assessing their content. Purchasing agencies may be ministries, insurance funds, local authorities, or other organizations. Their effectiveness depends on authority, credible information, provider availability, and the ability to enforce contracts.\n\nPayment methods create different incentives. Under fee-for-service, providers receive payment for individual consultations, tests, procedures, or other billable items. This can support activity and responsiveness but also encourage greater service volume, depending on prices and oversight. Salary payment offers predictable remuneration and can support activities that are difficult to bill individually, yet does not directly reward additional output. Neither method determines behavior alone: professional norms, staffing, clinical guidelines, and organizational management also influence practice.\n\nCapitation pays a fixed amount for each enrolled person over a specified period, usually for a defined range of services. Because revenue is not tied directly to each visit, it can encourage prevention and economical management. It may also create incentives to limit services or avoid patients with costly needs. Risk adjustment, minimum service requirements, patient choice, and quality monitoring can address these incentives. Capitation for primary care differs from a comprehensive payment that makes an organization financially responsible for hospital and specialist care as well.\n\nHospitals may receive line-item budgets, global budgets, payments per day, or payments per case. Line-item budgets specify categories such as salaries, medicines, and utilities, often limiting transfers between them. Global budgets set an overall spending envelope with varying degrees of managerial flexibility. Case-based payment commonly uses diagnosis-related groups to classify episodes with similar clinical characteristics and expected resource use. It may encourage shorter stays and greater activity, but also creates incentives for more admissions, changes in coding, or selection of less costly cases within a category.\n\nMost systems blend payment methods to balance competing incentives. A primary care organization might receive capitation, separate payments for selected services, and a performance-related component. Performance payments require reliable measures and safeguards against neglect of unmeasured activities. Paying for outcomes also raises attribution problems because results depend on factors beyond a provider’s control, including disease severity and social determinants of health. Procurement and payment for essential medicines add further choices, such as competitive tendering, negotiated prices, and reference pricing. Purchasing arrangements therefore require continuing assessment of access, expenditure, and quality of care, rather than reliance on one payment method."
    },
    {
      "heading": "Public budgets, expenditure control, and fiscal sustainability",
      "text": "Publicly financed healthcare operates within broader government budgets. Its resources depend on economic activity, revenue collection, debt obligations, competing expenditure commitments, and political decisions. Fiscal space for health refers to the capacity to increase or sustain health spending without undermining the government’s financial sustainability. It is not equivalent to an unallocated pot of money: it can arise through stronger revenues, changes in expenditure priorities, improved execution, or other adjustments whose feasibility varies by country.\n\nA basic accounting relationship helps distinguish economic growth from budget priority:\n\n\\[\\frac{H}{Y} = \\frac{H}{G} \\times \\frac{G}{Y},\\]\n\nwhere \\(H\\) is government health expenditure, \\(G\\) is total government expenditure, and \\(Y\\) is gross domestic product. The health share of the economy therefore depends both on the size of government spending relative to the economy and on the share of the government budget allocated to health. This identity describes expenditure; it does not establish an appropriate target or show whether spending is efficient.\n\nBudget allocations must be converted into usable resources. Public financial management includes budget formulation, legislative authorization, cash release, purchasing controls, accounting, and audit. A ministry may have an approved allocation yet receive funds late or be unable to move money between categories. Facilities may lack authority to purchase supplies even when local shortages are known. Low expenditure against an approved budget can reflect procurement delays, vacancies, unrealistic plans, or delayed cash releases rather than a lack of need.\n\nExpenditure growth reflects several interacting forces: population size and age structure, disease patterns, service utilization, wages, technology, and prices. Population ageing can increase demand, but its financial consequences depend on health status, service organization, and proximity to death, among other factors. Technological change can reduce the cost of an existing treatment, expand the number of treatable patients, or introduce additional services. Health expenditure therefore cannot be projected reliably from demographic change alone.\n\nControl mechanisms include expenditure ceilings, negotiated fees, pharmaceutical price regulation, procurement reform, and assessment of low-value services. These measures have different effects on access and provider behavior. A fixed budget can constrain spending but may produce queues or unpaid liabilities if obligations exceed resources. Underfunded purchasing commitments can generate arrears that shift financial pressure to providers and suppliers. Capital investment also creates recurrent obligations: a new hospital requires staff, maintenance, utilities, and supplies. Sustainable budgeting consequently links service commitments, payment rules, investment decisions, and realistic medium-term revenue expectations."
    },
    {
      "heading": "Measuring financial protection, equity, and performance",
      "text": "Health financing performance cannot be assessed through total expenditure alone. A country may spend heavily while maintaining uneven access or substantial household financial risk. Conversely, low spending may reflect either economical provision or serious unmet need. Measurement therefore combines resource levels with service coverage, financial protection, distribution, efficiency, and quality. Comparisons also require attention to prices, population characteristics, accounting boundaries, and the year of observation.\n\nThe System of Health Accounts 2011, developed jointly by the Organisation for Economic Co-operation and Development, the European Union, and the World Health Organization, provides an international framework for tracking health expenditure. It distinguishes financing schemes, sources of revenue, healthcare functions, and providers. Current health expenditure generally concerns consumption of health goods and services; capital formation is recorded separately. Expenditure as a share of GDP describes economic scale, while per-person expenditure adjusted for purchasing power provides a different comparison. Neither measure directly indicates the quantity or quality of services received.\n\nCatastrophic health expenditure occurs when household out-of-pocket health payments exceed a defined share of household resources. One widely used approach measures payments above 10% or 25% of total household consumption or income. Other methods use capacity to pay after accounting for basic needs. For household \\(h\\), a simplified indicator is:\n\n\\[C_h = \\mathbf{1}\\left( \\frac{O_h}{R_h} > z \\right),\\]\n\nwhere \\(O_h\\) is out-of-pocket health spending, \\(R_h\\) is the selected resource measure, \\(z\\) is the threshold, and \\(\\mathbf{1}\\) indicates whether the condition holds. Results depend materially on definitions and survey methods.\n\nImpoverishing health expenditure measures whether payments push households below a poverty line or deepen existing poverty. It complements catastrophic expenditure because a relatively small payment can be damaging for a household already near subsistence. Both measures have an important limitation: people who cannot afford care may spend nothing and therefore register no catastrophic payment. Financial protection indicators must consequently be read alongside unmet need and utilization data. The out-of-pocket share of national health expenditure is useful but cannot identify how burdens are distributed across households.\n\nHealth equity analysis examines differences by income, region, sex, age, disability, and other relevant characteristics. Benefit-incidence analysis estimates how public subsidies are distributed, while financing-incidence analysis examines the distribution of contributions. Interpretation requires care: greater expenditure on one group may reflect greater need, more expensive local provision, or unequal access to specialized care. Administrative data, household surveys, facility accounts, and electronic health records can illuminate different parts of the system, but inconsistent identifiers and incomplete coverage may prevent direct linkage."
    },
    {
      "heading": "External assistance, emergencies, and cross-border financing",
      "text": "External health assistance can finance services, medicines, workforce development, information systems, and infrastructure. It is particularly significant in some lower-income and crisis-affected countries. Funding may flow through governments, multilateral organizations, nongovernmental organizations, or dedicated programs. Grants and concessional loans have different financial implications, and announced commitments differ from money actually disbursed. Assistance also includes in-kind commodities and technical support, which may not appear in domestic budgets in the same way as cash transfers.\n\nGlobal initiatives have supported programs addressing HIV/AIDS, tuberculosis, malaria, and immunization, among other priorities. Gavi was established in 2000, and the Global Fund to Fight AIDS, Tuberculosis and Malaria was established in 2002. Their financing arrangements illustrate how international resources can support nationally delivered services while carrying program-specific requirements. Such funding can expand access, but earmarked grants may also create separate planning, reporting, procurement, and staffing arrangements alongside domestic systems.\n\nPredictability and transition are central concerns. Short funding cycles or delayed disbursements can interrupt medicine supply and employment contracts. When external support declines, domestic budgets may need to absorb procurement, salaries, and other recurrent obligations. A successful transition cannot be inferred from national income alone: revenue collection, disease burden, debt pressures, and administrative capacity influence whether replacement funding is available. Integration of externally funded activities into domestic purchasing and budget systems affects continuity.\n\nHealth emergencies reveal the limits of ordinary financing arrangements. During the COVID-19 pandemic, governments financed additional testing, treatment, vaccination, supplies, and health-system capacity through supplementary budgets and other emergency mechanisms. Routine provider revenue also fell in some settings when services were postponed or attendance declined. Emergency financing therefore had to address both additional demand and disruption of existing revenue flows. Rapid procurement and accelerated transfers increased the importance of expenditure tracking, audit, and transparent contracting.\n\nPreparedness poses a different financing problem from response. Laboratories, trained personnel, surveillance, stockpiles, and surge arrangements require continuing support even when no emergency is occurring. Their benefits may extend across borders, making national financing alone an incomplete solution. International mechanisms, including the Pandemic Fund established in 2022, seek to support preparedness capacity. At the domestic level, contingency appropriations, reserve funds, and prearranged emergency procedures can make resources available more quickly, but money remains only one constraint: trained workers, manufacturing capacity, logistics, and functioning institutions determine whether additional financing can be converted into timely services."
    }
  ],
  "links": [
    "health-system",
    "universal-health-coverage",
    "economics",
    "surgery",
    "adverse-selection",
    "moral-hazard",
    "public-health-surveillance",
    "united-kingdom",
    "united-states",
    "japan",
    "taxation",
    "disease-prevention",
    "quality-adjusted-life-year",
    "disability-adjusted-life-year",
    "primary-care",
    "social-determinants-of-health",
    "essential-medicines",
    "quality-of-care",
    "gross-domestic-product",
    "public-financial-management",
    "world-health-organization",
    "health-equity",
    "hiv-aids",
    "tuberculosis",
    "malaria"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}